{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:25:50Z","timestamp":1790774750841,"version":"4.1.0"},"reference-count":10,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2025,7,23]]},"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1183\/13993003.00768-2025","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:50:19Z","timestamp":1754581819000},"page":"2500768","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Pericardial effusion in sotatercept phase 3 trials: insights from STELLAR and ZENITH"],"prefix":"10.1183","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9086-2293","authenticated-orcid":false,"given":"Marius M.","family":"Hoeper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1378-7362","authenticated-orcid":false,"given":"Ioana R.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardi","family":"Gomberg-Maitland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7797-0361","authenticated-orcid":false,"given":"Aaron B.","family":"Waxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald S.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vallerie V.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-2892","authenticated-orcid":false,"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the STELLAR and ZENITH trial investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"2025092508001167000_66.3.2500768.1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-3033"},{"key":"2025092508001167000_66.3.2500768.2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.chest.2022.04.011","article-title":"Prognostic value of echocardiographic variables prior to and following initiation of parenteral prostacyclin therapy: an observational study","volume":"162","author":"Shah","year":"2022","journal-title":"Chest"},{"key":"2025092508001167000_66.3.2500768.3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ahj.2017.04.013","article-title":"High-risk echocardiographic features predict mortality in pulmonary arterial hypertension","volume":"189","author":"Austin","year":"2017","journal-title":"Am Heart J"},{"key":"2025092508001167000_66.3.2500768.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.09.016"},{"key":"2025092508001167000_66.3.2500768.5","doi-asserted-by":"publisher","DOI":"10.1111\/echo.12909"},{"key":"2025092508001167000_66.3.2500768.6","unstructured":"Keros Therapeutics, Inc . Form 8 (k), Current Report. May 29, 2025. Date last accessed: 11 June 2025. www.sec.gov\/Archives\/edgar\/data\/1664710\/000166471025000052\/exhibit992.htm"},{"key":"2025092508001167000_66.3.2500768.7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2213558"},{"key":"2025092508001167000_66.3.2500768.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2415160"},{"key":"2025092508001167000_66.3.2500768.9","doi-asserted-by":"crossref","first-page":"e011227","DOI":"10.1161\/CIRCHEARTFAILURE.123.011227","article-title":"SPECTRA Phase 2b study: impact of sotatercept on exercise tolerance and right ventricular function in pulmonary arterial hypertension","volume":"17","author":"Waxman","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2025092508001167000_66.3.2500768.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024277"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00768-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:00:17Z","timestamp":1758812417000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00768-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":10,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9,25]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1183\/13993003.00768-2025"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00768-2025","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]}}}